-

DeciBio Ranked Among the Best Consulting Firms by GenomeWeb, Vault Consulting 50, and Management Consulted

LOS ANGELES--(BUSINESS WIRE)--DeciBio has earned recognition in the most prominent rankings in its field: GenomeWeb, The Vault Consulting 50, and Management Consulted.

GenomeWeb, a leading online news source for the life sciences industry, awarded DeciBio as the winner of its Best Places to Work Award in the 26-50 Employee category. Likewise, The Vault Consulting 50 placed DeciBio on its list of the best consulting companies to work for in North America, including top-10 overall rankings in Innovation, Leadership, Diversity regarding LGBTQ+, Diversity regarding Women, Selectivity, and Company Culture subcategories. Meanwhile, Management Consulted placed DeciBio on its list of the top-9 “Industry-Focused Firms,” citing DeciBio’s startup culture, data analytics, deep industry expertise, and professional growth opportunities.

Each publication emphasized DeciBio’s uniquely entrepreneurial culture, community spirit, and quality of life.

Due to its belief that the best workplaces empower team members with real opportunities to grow, lead, and innovate, DeciBio has focused on nurturing an entrepreneurial mindset at every level of the organization. Immediately in their careers at DeciBio, team members are empowered to take initiative, punch above their weight, pursue their passions, and make a meaningful impact. As highlighted by GenomeWeb, employees demonstrating readiness are quickly entrusted with greater responsibility, fostering a dynamic environment of continuous learning and leadership development. This entrepreneurial approach is echoed by Vault, which highlighted that DeciBio “offers employees the excitement and hands-on learning opportunities of a startup environment merged with the deep content knowledge and professional development opportunities of a larger consulting firm.”

The firm places a strong emphasis on community spirit, whether in team-building activities or informal mentorship, DeciBio fosters a supportive culture where every voice is heard and contributions are valued. Additionally, DeciBio is dedicated to providing a high quality of life for its employees. Vault highlights how DeciBio insiders appreciate the firm’s supportive environment, commitment to flexibility, and trust in its employees, making it possible to build a fulfilling quality of life.

“The recognition we’ve received from GenomeWeb, Vault, and Management Consulted is a testament to the exceptional people who make DeciBio a special place to work. We’re proud of the culture we’ve built and remain committed to offering an environment where our employees can grow, innovate, and make a real impact in the world of precision medicine,” said Andrew Aijian, Senior Partner at DeciBio.

About DeciBio:

DeciBio Consulting (www.decibio.com) is the leading strategy consulting, market intelligence, and SaaS firm dedicated to accelerating innovation in precision medicine.

DeciBio provides strategic advisory services to companies and organizations in the life sciences sector, with a particular focus on life science research tools, diagnostics, and precision therapeutics. The firm specializes in emerging markets such as liquid biopsy for early cancer detection, multiplex spatial tissue analysis, and cell and gene therapy manufacturing. Additionally, DeciBio supports biopharma clients in the commercialization of companion diagnostics (CDx) and broader R&D strategies. With a strong presence in Private Equity M&A, particularly within the tools space, DeciBio also leverages its expertise in proteomics to guide clients through complex market dynamics and growth opportunities.

Headquartered in Los Angeles, California, DeciBio serves a global base of clients and customers, ranging from startups to Fortune 500 healthcare corporations. DeciBio offers advisory services for growth planning, market and opportunity assessment, product and portfolio strategy, voice-of-customer feedback, technology assessment, and commercial due diligence.

Contacts

DeciBio Consulting
Elle Nouveau
careers@decibio.com
310.451.4510

DeciBio Consulting


Release Versions

Contacts

DeciBio Consulting
Elle Nouveau
careers@decibio.com
310.451.4510

Social Media Profiles
More News From DeciBio Consulting

Worldwide Digital & Computational Pathology Market Forecasted to Grow at 12% p.a., Reaching $2.1B by 2031 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC’s latest market report, “Digital & Computational Pathology Market Report 2026-2031,” states that the global digital pathology market, driven by an influx of open platforms that resolve interoperability challenges and standalone regulatory clearances that enable greater clinical adoption, is predicted to reach $2.1B by 2031. The third edition of DeciBio’s digital and computational pathology (D&CP) report takes a comprehensive look at t...

Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 27% p.a., Reaching ~$17B by 2031 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting has released the fourth edition of its Oncology Liquid Biopsy Market Report, offering updated global estimates of how liquid biopsy technologies are being applied across clinical and pharmaceutical research settings. The report draws on in-depth interviews with more than 30 experts in the field, including medical oncologists, biopharma researchers, technology providers, and other key healthcare stakeholders to capture the dynamic and evolving liq...

Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets – Data Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe’s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a cross-market view of current priorities, barriers, and areas of momentum. The Europe Oncology Genomics Tracker char...
Back to Newsroom